Gaining regulatory approval for drugs targeting conditions that cannot ethically be studied in humans presents a unique ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

(Reuters) — The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with “human-relevant methods,” ...

Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a new initiative to significantly reduce, refine, and replace animal testing ...

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...

Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...

In recent months, the Food and Drug Administration and National Institutes of Health have announced new initiatives to reduce and replace animal testing in biomedical research. Central to these ...

A high drug failure rate is more than just a pattern recognition problem. Thom Leach/Science Photo Library via Getty Images The potential of using artificial intelligence in drug discovery and ...

The last few weeks have been busy for Jim Corbett. Corbett, the CEO of organ-chip developer Emulate, has been fielding requests from potential clients, as well as from early investors who say they ...

For decades, preclinical testing in mice, rats, and nonhuman primates has been a crucial part of drug development, an important although not infallible way to ensure some measure of safety for human ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced a major policy shift to reduce reliance on animal testing in the evaluation of monoclonal antibodies and other drugs. The ...